SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -96.9% | 18,983 | -49.2% | 0.00% | – |
| Q3 2018 | $64,000 | +14.3% | 37,355 | +15.5% | 0.00% | – |
| Q2 2018 | $56,000 | -80.7% | 32,355 | -79.6% | 0.00% | -100.0% |
| Q1 2018 | $290,000 | +302.8% | 158,405 | +393.4% | 0.00% | – |
| Q4 2017 | $72,000 | -27.3% | 32,105 | -6.1% | 0.00% | – |
| Q3 2017 | $99,000 | -85.3% | 34,205 | -77.6% | 0.00% | -100.0% |
| Q2 2017 | $675,000 | +12.7% | 152,705 | +17.8% | 0.00% | 0.0% |
| Q1 2017 | $599,000 | -20.9% | 129,645 | +4.3% | 0.00% | -40.0% |
| Q4 2016 | $757,000 | -19.0% | 124,285 | -26.8% | 0.01% | -16.7% |
| Q3 2016 | $935,000 | +109.6% | 169,755 | +44.6% | 0.01% | +100.0% |
| Q2 2016 | $446,000 | +39.4% | 117,436 | +1.3% | 0.00% | +50.0% |
| Q1 2016 | $320,000 | +932.3% | 115,986 | +2008.8% | 0.00% | – |
| Q4 2015 | $31,000 | -49.2% | 5,500 | -52.2% | 0.00% | -100.0% |
| Q3 2015 | $61,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |